Lapatinib/Trastuzumab Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C138040
A chemotherapy regimen consisting of lapatinib and trastuzumab, used as a treatment for recurrent and metastatic HER-2/neu-positive breast cancer. [ ]
Term info
Label
Lapatinib/Trastuzumab Regimen
Synonyms
- Lapatinib + Trastuzumab
- Lapatinib + Trastuzumab Regimen
- Lapatinib Plus Trastuzumab
- Lapatinib/Trastuzumab
- Lapatinib/Trastuzumab Regimen
Subsets
NCIT_C160952, NCIT_C160950
DesignNote
Source: NCCN Guidelines 2017
Preferred Name
Lapatinib/Trastuzumab Regimen
Semantic Type
Therapeutic or Preventive Procedure
UMLS CUI
C1541246
code
C138040